Ono Pharmaceutical (OTCMKTS:OPHLF) Stock Crosses Above Fifty Day Moving Average – Should You Sell?

by · The Markets Daily

Ono Pharmaceutical Co. (OTCMKTS:OPHLF – Get Free Report)’s share price crossed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $15.09 and traded as high as $15.16. Ono Pharmaceutical shares last traded at $15.16, with a volume of 100 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded shares of Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research report on Friday, September 4th. One investment analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Get Our Latest Analysis on Ono Pharmaceutical

Ono Pharmaceutical Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 3.28 and a quick ratio of 2.86. The company has a 50-day simple moving average of $15.09 and a 200-day simple moving average of $14.67. The stock has a market cap of $7.12 billion, a PE ratio of 14.44 and a beta of 0.38.

Ono Pharmaceutical Company Profile

(Get Free Report)

Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses primarily on oncology, immunology, neurology and other specialty therapeutic areas, with an emphasis on discovering treatments for diseases with significant unmet medical needs.

Ono’s best-known product is Opdivo (nivolumab), an immuno-oncology medicine developed in collaboration with Bristol Myers Squibb and approved for multiple cancer indications in various markets.

Featured Articles